Do you have Recurrent endometrial cancer,Recurrent, high-grade serous epithelial ovarian, primary peritoneal, or fallopian tube cancer that has progressed during or after standard treatments? If so, you may be able to take part in a research study looking at the safety of giving a treatment of test drug IMGN151-1001 to patients with these types of cancer

Have you been diagnosed with aggressive B-cell lymphomas and received CAR-T treatment? If so, you may be able to take part in a research study. This study is looking at the efficacy of giving an investigational drug called Epcoritamab in comparison with no treatment. The participants should have received CAR-T treatment but did not have complete remission.

Do you have kidney or bladder cancer. You may be able to participate in a research study to find out if the investigational drug REGN10597 is safe, tolerable, and effective in treating kidney and bladder cancer.

Do you have problems with your thinking or memory? Or a parent or sibling with dementia? If so, we'd like you to join this registry about the brain and Alzheimer's disease. In return for providing us with a little bit of your health history and background, we will connect you with researchers doing studies you can join, without obligation. Many studies pay a stipend and some offer a possible treatment.

Are you the parent of a female 13-15 year old teen? Do you have a history of depression? If so, you and your teen may be able to participate in a study looking at teenager's brain responses, emotions, social interactions, and depression risk. Families can be paid up to $375 for their participation in the study.

Do you have Stage III or Stage IV Non-Small Cell Lung Cancer? Do you have a KRAS G12C mutation or are you interested in testing for this? If so, you may be able to participate in a study to see if adding a new medicine is more effective at controlling your cancer than the usual treatments.

Do you have bladder cancer that has spread to nearby tissue or other parts of the body? You may be able to participate in a research study to find out if the investigational drug disitamab vedotin alone or with pembrolizumab works to treat bladder cancer.

Have you ever been concerned about your eating? We're inviting adults in the U.S. who have ever had anorexia nervosa, atypical anorexia nervosa, bulimia nervosa, binge-eating disorder, or avoidant/restrictive food intake disorder (ARFID) at any point in their life to take our survey. No official medical diagnosis is required. Common signs of different eating disorders may include: restricting the amount or type of food you eat or eating excessive amounts of food in one sitting. Some other possible signs are making yourself throw up, using diet pills or laxatives, excessively exercising, or fasting to alter your weight. Only with your help can we the causes and potential cures for these disorders. Eligible participants who complete Core Questionnaires and return their saliva sample will receive a $30 gift card.

Do you want to experience a nurturing, empowering and wellness-centered prenatal care that helps you reduce the chance of getting diabetes in pregnancy? Then the Targeted Lifestyle Change (TLC) Study might be for you! TLC is specially designed to help you learn how to eat, move, and live for two during pregnancy to explore whether we can reduce the risks of diabetes in pregnancy. Compensation provided.

Do you have bladder cancer and have had your bladder removed? If so, you may be able to take part in a research study to determine if patients need additional treatment called immunotherapy to prevent cancer from coming back.